chartexchange

SLDB
Solid Biosciences Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 3:05:32 PM EST
6.36USD+0.157%(+0.01)912,997
6.3500Bid6.3600Ask0.0100Spread
Loading…
Loading…
711.52M
Healthcare
Biotechnology
HQ
Charlestown, MA, USA
Previous Close
$6.35
Beta
2.08
52-Week High
$11.45 2026-07-06
52-Week Low
$4.40 2025-11-19
SMA 50
$6.98
SMA 200
$7.68
Avg. Vol 10D
1.44M
Avg. Vol 30D
1.37M
Avg. Vol 90D
1.18M
Relative Vol
0.67
111.61M
91.06M
13,303,890
0.4100%
126
Oct 28, 2022 · 1-for-15 (reverse)
SLDB Profile

solid biosciences (solid) is a cambridge, ma based biotech company singularly focused on developing treatments and cures for duchenne muscular dystrophy (dmd). solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of dmd.

SLDB Performance
PeriodPriceDateChangeBeta
1W7.002026-11-12-8.93%3.395
1M5.922026-10-19+7.69%2.346
3M9.742026-08-19-34.55%2.219
6M6.082026-05-19+4.85%2.013
1Y4.482025-11-19+42.30%2.077
2Y5.112024-11-19+24.75%—
5Y29.852021-11-19-78.64%1.390
SLDB Stock Summary

Solid Biosciences Inc. Common Stock (NASDAQ:SLDB) stock price today is $6.38, and today's volume is 912,722. SLDB is up 0.394% today. The 30 day average volume is 1.37M. SLDB market cap is $711.52M with 111.61M shares outstanding.